Wiley Bros. Aintree Capital, LLC United Therapeutics Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 1,266 shares of UTHR stock, worth $465,077. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,266
Previous 625
102.56%
Holding current value
$465,077
Previous $223,000
100.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
723Shares Held
60.9MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$6.73 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$2.01 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.63 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$1.01 Billion14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$905 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...